Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1977 1
1982 1
1983 1
1994 1
1997 1
2010 1
2011 2
2012 2
2013 1
2014 2
2015 6
2016 6
2017 6
2018 11
2019 5
2020 5
2021 11
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Five-year Weight Loss Maintenance With Obesity Pharmacotherapy.
Weintraub MA, D'Angelo D, Tchang BG, Sahagun AD, Andre C, Aronne LJ, Shukla AP. Weintraub MA, et al. Among authors: shukla ap. J Clin Endocrinol Metab. 2023 Aug 18;108(9):e832-e841. doi: 10.1210/clinem/dgad100. J Clin Endocrinol Metab. 2023. PMID: 36810608 Free PMC article.
The impact of food order on postprandial glycaemic excursions in prediabetes.
Shukla AP, Dickison M, Coughlin N, Karan A, Mauer E, Truong W, Casper A, Emiliano AB, Kumar RB, Saunders KH, Igel LI, Aronne LJ. Shukla AP, et al. Diabetes Obes Metab. 2019 Feb;21(2):377-381. doi: 10.1111/dom.13503. Epub 2018 Sep 10. Diabetes Obes Metab. 2019. PMID: 30101510 Free PMC article. Clinical Trial.
Pharmacotherapy for Obesity.
Saunders KH, Shukla AP, Igel LI, Kumar RB, Aronne LJ. Saunders KH, et al. Among authors: shukla ap. Endocrinol Metab Clin North Am. 2016 Sep;45(3):521-38. doi: 10.1016/j.ecl.2016.04.005. Endocrinol Metab Clin North Am. 2016. PMID: 27519128 Review.
Nonalcoholic steatohepatitis, obesity, and cardiac dysfunction.
Mathews SE, Kumar RB, Shukla AP. Mathews SE, et al. Among authors: shukla ap. Curr Opin Endocrinol Diabetes Obes. 2018 Oct;25(5):315-320. doi: 10.1097/MED.0000000000000432. Curr Opin Endocrinol Diabetes Obes. 2018. PMID: 30074500 Review.
An update on pharmacotherapeutic strategies for obesity.
Tchang BG, Tarazi MS, Aras M, Shukla AP. Tchang BG, et al. Among authors: shukla ap. Expert Opin Pharmacother. 2021 Jul;22(10):1305-1318. doi: 10.1080/14656566.2021.1888927. Epub 2021 Feb 18. Expert Opin Pharmacother. 2021. PMID: 33599159 Review.
Obesity: When to consider medication.
Saunders KH, Shukla AP, Igel LI, Aronne LJ. Saunders KH, et al. Among authors: shukla ap. J Fam Pract. 2017 Oct;66(10):608-616. J Fam Pract. 2017. PMID: 28991935 Review.
Treatment of obesity in 2015.
Shukla AP, Buniak WI, Aronne LJ. Shukla AP, et al. J Cardiopulm Rehabil Prev. 2015 Mar-Apr;35(2):81-92. doi: 10.1097/HCR.0000000000000112. J Cardiopulm Rehabil Prev. 2015. PMID: 25714749 Review.
Pharmacotherapy for obesity in individuals with type 2 diabetes.
Chukir T, Shukla AP, Saunders KH, Aronne LJ. Chukir T, et al. Among authors: shukla ap. Expert Opin Pharmacother. 2018 Feb;19(3):223-231. doi: 10.1080/14656566.2018.1428558. Epub 2018 Jan 29. Expert Opin Pharmacother. 2018. PMID: 29376439 Review.
66 results